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S U M M A R Y
Background: Scabies is a disease that is considered a public health problem in the Palestinian Territories
and in other countries around the world. Scabies causes skin lesions leading to substantial morbidity,
and is also associated with social stigma. In this study we describe the epidemiology of scabies in the
West Bank, Palestine during the years 2005–2010.
Methods: We examined the records and proﬁles of a total of 1734 patients who were admitted to the
dermatology clinics of the Palestinian Ministry of Health in 2005–2010.
Results: The disease was found to be prevalent in all governorates. The average annual incidence of
scabies in the West Bank for 2005–2010 was 17/100 000 population. The average number of scabies
patients per year in the West Bank was 26.3 per governorate, with a signiﬁcant increase in the years 2009
and 2010 (p < 0.001). Disease occurrence was signiﬁcantly higher among children aged 10 years than
in the other age groups, in adult females in the age groups of 31–40 and 41–50 years compared to males
in these age groups, and in males in the age group of 11–20 years compared to females in that age group.
Conclusions: Scabies was found in all governorates of the Palestinian West Bank. Individuals under 20
years of age are particularly at risk. Compulsory reporting of scabies to the Palestinian Ministry of Health
would be expected to increase awareness of the disease, which is crucial for the prevention and control of
scabies in the Palestinian Territories.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Scabies is a highly contagious skin disease that is on the
increase and afﬂicts all races and social classes in every nation. The
global prevalence has been conservatively estimated at around 300
million cases.1 This disease is caused by the ectoparasitic mite of
mammalian skin, Sarcoptes scabiei var. hominis. These mites are
able to survive away from the host for 24–36 h at 21 8C and 40–80%
relative humidity, and remain infective.2,3 At lower temperatures
and higher humidity, these mites are able to remain infective away
from the host for about 1 week and are able to penetrate the skin at
a temperature above 20 8C.4
Although scabies itself is not a fatal or life-threatening
condition, it can be severe and persistent, leading to debilitation
and discomfort, depression, and secondary skin infections.
Affected individuals may be asymptomatic or present varied skin
eruptions, including papules, nodules, blisters, and eczematous
changes, superimposed with excoriations and bacterial infections.
Post-infective complications such as acute post-streptococcal* Corresponding author. Tel.: +972 599197097; fax: +972 22796960.
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doi:10.1016/j.ijid.2011.10.005glomerulonephritis are common.5 The disease is prevalent in all
socioeconomic groups and communities throughout the world.6
Scabies is one of the diseases that carries a high social stigma, such
that patients hesitate to seek medical treatment.
The prevalence of scabies varies widely from one country to
another.7 In developing countries the prevalence of the disease is
about 5.8–8.3% among rural populations.8–10 The situation is
worsening in underdeveloped countries in Africa, where preva-
lence ranges from 2% to 31%.11–14 In the Arab countries like Egypt,
the prevalence of the disease is about 2.6%.15 However, very few
studies have been reported from other countries in the Arab World.
The diagnosis of scabies is made by ﬁnding a typical scabies
burrow in the skin, especially in immunocompromised children
and the elderly. Incubation periods, the number of mites carried,
and the intensity of the itch are variable. Although the presence of
burrows is not always obvious in certain cases, infection of one
individual often spreads to all members of the family.2,16 The
occurrence of itchy papules, papular crusts, or vesicular lesions is
suggestive of scabies. An individual is diagnosed to have scabies
when one or more typical lesions are present and last for longer
than 2 weeks, when pruritus intensiﬁes at night, or when at least
one other family member has similar lesions.17 Scabies is not a
highly complicated infectious disease; patients can be treated withses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Map of the West Bank, Palestinian Territories, showing the average
number of patients per year, and in parenthesis the average annual incidence rate of
scabies, calculated for each governorate for the years 2005–March 2011. The table
indicates the population of each governorate in the middle of the year 2010.
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been reported from the West Bank, Palestinian Territories, a high
rate of infection has been reported among school children aged less
than 10 years, especially in poor and large families, in Gaza.20
Scabies in the Palestinian Territories is not mandated as a
reportable disease by the Palestinian Ministry of Health (PMOH).
This study was performed to estimate the prevalence of scabies in
the Palestinian West Bank by analyzing the available epidemio-
logical data from the PMOH dermatology clinic records, and to
determine the possible factors associated with scabies distribution
and transmission.
2. Materials and methods
2.1. Study design
A descriptive epidemiological study based on PMOH dermatol-
ogy clinic records and patient proﬁles was conducted between
2005 and 2010. One thousand seven hundred and thirty-four
scabies patients were recorded by the PMOH directorates in the 11
governorates of the West Bank during the period 2005–2010. Due
to changes in the reporting system of the PMOH, only 1241 patient
proﬁles, which included information on age, gender, geographical
origin, date of diagnosis, patient profession, and treatment, were
available. Cases without a patient proﬁle (total 493) were recorded
by the directorates of health as numbers, but without details.
Scabies was diagnosed clinically by the presence of burrows or
erythematous papular, vesicular, or pustular lesions with itching.
In most cases, the microscopic detection of mites, eggs, or feces
was not done. This was not considered a reportable disease by the
PMOH, hence some patient records were not available.
2.2. Study area and population
Visits were arranged to all PMOH directorates in all Palestinian
governorates in the West Bank, and all scabies records and patient
proﬁles for the period 2005–2010 were inspected and patient
information collected. The West Bank is located west of the Jordan
River (32 00 N, 35 15 E). It has a land area of 5640 km2 (including
East Jerusalem) and a population of 2 514 845 people (June 2010),
as reported by the Palestinian Central Bureau of Statistics (PCBS;
http://www.pcbs.gov.ps/). The population is distributed across 11
governorates as follows: Hebron, Bethlehem, Jerusalem, Ramallah,
Jericho, Tubas, Salﬁt, Nablus, Qalqilya, Tulkarem, and Jenin.
Figure 1 shows a map of the locations of the study governorates.
2.3. Data analysis
The average annual incidence rates were calculated per 100 000
population for the years 2005–2010 for each governorate. The
average number of cases per year was calculated for each
governorate, age group, and gender during the study period. The
male to female ratio was calculated for each age group and Chi-
square statistics were calculated to identify signiﬁcant differences
in disease incidence with regard to the study variables, such as
season, gender, and age. Signiﬁcance was set at the level of 0.05.
Statistical analyses were carried out using the Statistical Package
for the Social Sciences SPSS 16.0 (SPSS Inc., Chicago, IL, USA).
2.4. Ethical considerations
The study protocol was revised and approved by the ethical
committee of Al-Quds University. Written permission to perform
the study was obtained from the PMOH. Prior to study
commencement meetings were held with community healthauthorities and the objectives of the study were explained. All
patient records and private data were handled conﬁdentially.
3. Results
One thousand seven hundred and thirty-four patient proﬁles
were investigated in this study. According to PMOH protocols, the
diagnosis of scabies should be made by a dermatologist in a
dermatology clinic. The clinical diagnosis usually relies on the
presence of papules and marks of pruritus on the hands, limbs, and
genitalia. In most cases, microscopic detection of mites, eggs, or
feces was not done. Patients were treated with 5% permethrin
dermal cream. Resistance to treatment with permethrin has not
been reported by the PMOH.
The average annual incidence rate of scabies in the West Bank
during the period 2005–2010 based on 1734 patients was 17/
100 000 population. The average annual incidence rate for the
individual governorates ranged from 1.3/100 000 population in
Tubas governorate to 41.4/100 000 population in Jericho gover-
norate. In the West Bank the average number of patients per year
over the 6-year period was 26.3 per governorate; this ranged from
0.7 in Tubas governorate to 77.2 in Jenin governorate. The average
annual incidence rates and the average number of patients per year
for each governorate individually are shown in Figure 1. Patient age
ranged from 1 month to 93 years, with a median of 21.3 years;
mean age was 32.6 years, with a standard deviation of 15.6 years.
The average numbers of patients per governorate in the years
2005, 2006, 2007, and 2008 were 21.4, 15.5, 13.3, and 24.1,
respectively, while this almost doubled in the years 2009 and 2010,
to 43.4 and 40.1 patients, respectively. The average number of
patients was signiﬁcantly increased in the years 2009 and 2010
compared to the years 2005–2008 (p < 0.001) (Table 1). The
majority of cases (65%) occurred during the winter time (October–
March) and cases declined during the summer time.
Table 2












10 333 27% 185 (15%) 148 (12%) >0.05
11–20 259 21% 156 (13%) 103 (8%) <0.01
21–30 165 13% 96 (8%) 69 (6%) >0.05
31–40 128 10% 44 (4%) 84 (7%) <0.01
41–50 167 13% 68 (5%) 99 (8%) 0.01
51 189 15% 95 (8%) 94 (8%) >0.05
Total 1241 100% 644 (52%) 597 (48%) >0.05
a Male vs. female, based on Chi-square statistics; p  0.05 was considered
signiﬁcant.
Table 1
Numbers of scabies cases in the West Bank per year, 2005–2010
2005 2006 2007 2008 2009 2010
Total number of patientsa 235 170 146 265 477 441
Average per governorate 21.4 15.5 13.3 24.1 43.4 40.1
a For all 11 governorates, each year.
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whether infection with scabies among Palestinians was correlated
with gender; 52% of the patients were male and 48% were female
(Table 2). The male to female ratio was 1.08. There were no
signiﬁcant differences in disease frequency between males and
females when all age groups were analyzed together (p > 0.05).
An analysis of scabies infestation across age groups together
with gender was conducted; patients were assigned to one of six
age groups and the percentage out of the total cases was calculated
for each group. Percentages of male and female patients were
calculated for each age group to investigate the role of gender and
age together (Table 2).
Approximately half of the cases (48%) were under 20 years of
age. Disease occurrence was signiﬁcantly higher among children
aged 10 years (27%) compared to the other age groups in the
study (p < 0.001). No signiﬁcant differences were found between
males and females in the age group 10 years (p > 0.05).
Interestingly, scabies incidence was signiﬁcantly higher in adult
females than males in the age groups 31–40 (p < 0.01) and 41–50
years (p = 0.01), and was signiﬁcantly higher in males than females
in the age group 11–20 years (p < 0.01). No gender difference was
found for age groups 21–30 years and 51 years.
4. Discussion
In this study we described the epidemiology of scabies in the
West Bank, Palestine during the years 2005–2010. The disease is
prevalent in all age groups and is distributed across all the
governorates of the West Bank. A standard diagnosis and
treatment protocol is applied by the PMOH. However, the
microscopic detection of mites, eggs, or feces was not done for
all patients. It is widely known that scabies mimics other skin
diseases, hence the detection of mites in all patients should be
mandatory. Information on treatment resistance and relapses was
not available, thus a better treatment follow-up system should be
established. The distribution of scabies throughout the West Bank
is uneven, since the average incidence rates varied among
governorates, ranging from 1.3/100 000 population in Tubas to
41.4/100 000 population in Jenin, compared to the average across
all the governorates in the West Bank of 17/100 000 population.
The reason why the Tubas governorate had the lowest average
annual incidence rate (1.3/100 000 population) and the lowest
average number of patients per year (0.7) for 2005–2010, is that
prior to 2008 all patients from this area pertained to the PMOHdirectorate in Jericho, where diagnosis and treatment were
provided. In the year 2008 the PMOH established an independent
health directorate in Tubas, and since then all patients have been
handled there. Accordingly, Jericho had the highest average annual
incidence rate in the West Bank for the years 2005–2010 (41.4/
100 000 population); it was previously thought that all the cases
originated from Jericho, while in fact they were also from the
neighboring Tubas area. Due to the ﬂawed reporting system of
scabies by the PMOH clinics, it was not possible to distinguish
between cases infected and treated in Jericho and cases infected in
Tubas and treated in Jericho, thus a better centralized reporting
system is needed to better understand the disease distribution.
Moreover, no reports on patients who could have been diagnosed
and treated in private clinics were available. It appears that a
network reporting system between private clinics and the PMOH
for cases of scabies does not exist; this is because the disease itself
is not a mandatory reportable disease in the Palestinian Territories.
A signiﬁcant increase in scabies incidence was noted for the
years 2009 and 2010 compared to the years 2005–2008
(p < 0.001). This could be the result of an improved recording of
patients by the PMOH personnel; however other factors, such as
differences in hygiene practices, changes in economic status, or
differences in social attitudes, should not be excluded. A
seasonality of scabies morbidity was noticed. Sixty-ﬁve percent
of the patients were reported in the winter (October–March). A
probable explanation for this seasonality of disease in the
Palestinian Territories is that cold weather may encourage
overcrowding and therefore an increase in transmission; this is
in agreement with previous reports from other countries.21–24
Another explanation might considered: cold and humid weather
may prolong mite survival.23 Further research focusing on possible
risk factors and the climatic conditions behind the occurrence of
scabies in the Palestinian Territories is needed. Better reporting of
the disease by the PMOH, together with case–control studies, may
lead to the identiﬁcation of people at high risk of the disease and
hence aid in the prevention and control of this disease.
No signiﬁcant difference was found in the incidence or
prevalence of scabies between males and females in this study;
this is in agreement with other studies from Denmark,22 Poland,10
Brazil,17 and Egypt.15 However, studies from Israel25 and the UK26–
28 have reported higher incidence among females, and a study from
Tunisia reported a higher incidence among males.29 This inconsis-
tency could not be explained and might be attributable to racial
factors, as well as private or hidden factors in each society and/or
country. Therefore, a global meta-analysis is recommended to
better understand the role of gender in scabies prevalence
worldwide.
Although males and females in all age groups in the West Bank
are vulnerable to scabies, the disease occurrence was found to be
relatively higher among individuals aged < 20 years (48%). This
result is consistent with other epidemiological reports from other
Arab countries like Egypt15 and Iraq.30 However a few reports have
shown a signiﬁcantly higher incidence among the elderly.31 The
higher occurrence of scabies among children aged 10 years and in
women aged 31–50 years (mother or nursemaid age) in the
Palestinian Territories may be attributed to the fact that babies and
small children are handled by women in this age group. In general,
there is closer physical contact between children and women or
siblings than between children and adult men. This may lead to
different transmission rates between groups of people and explain
the variations in incidence by age and gender.27
Further investigations on the coincidence of scabies and other
dermatological disorders in children and adults, such as impetigo
and head lice, is recommended in order to better understand the
disease dynamics across the different age groups. Secondary
bacterial skin infections should also be considered.
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our study. This study was based on patients handled and treated at
PMOH clinics; however data on patients who were treated at
private dermatology clinics were not available. Nevertheless, most
scabies patients in the West Bank live in low socioeconomic
conditions (author’s personal observation) and cannot afford the
high costs of diagnosis and treatment at a private clinic.
Consequently, the majority of the patients seek treatment at the
PMOH clinics. Accordingly, the scabies morbidity presented in our
study is likely to reﬂect the true trends.
In conclusion, scabies should be handled as a reportable disease
in the Palestinian Territories and the reporting system should be
compulsory. This epidemiological study provides a ﬁrst insight into
the scabies infection status in the Palestinian West Bank, Palestinian
Territories, based on the examination of patient records available
from the PMOH. Prevention and control measures should be directed
to increase awareness and better scabies recognition, improve the
education of the medical staff at the health units, improve hygiene
measures, and implement massive treatment campaigns.
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